Clark Financial Services Group Inc Tg Therapeutics, Inc. Transaction History

Clark Financial Services Group Inc

$184 Million
Q3 2025

A detailed history of Clark Financial Services Group Inc transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Clark Financial Services Group Inc holds 20,000 shares of TGTX stock, worth $620,000. This represents 0.39% of its overall portfolio holdings.

Number of Shares

20,000

Previous 18,805 6.35%

Holding current value

$620,000

Previous $676,000 6.8%

% of portfolio

0.39%

Previous 0.42%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 31, 2025	BUY	$26.39 - $39.19 $31,536 - $46,832	1,195 Added 6.35%	20,000 $722,000
Q2 2025 Aug 12, 2025	SELL	$33.37 - $45.51 $15,350 - $20,934	-460 Reduced 2.39%	18,805 $676,000
Q1 2025 May 15, 2025	BUY	$27.67 - $42.99 $151,465 - $235,327	5,474 Added 39.69%	19,265 $759,000
Q4 2024 Feb 13, 2025	SELL	$21.31 - $35.09 $1,726 - $2,842	-81 Reduced 0.58%	13,791 $415,000
Q2 2024 Aug 13, 2024	SELL	$13.32 - $19.19 $519 - $748	-39 Reduced 0.28%	13,872 $246,000
Q1 2024 May 14, 2024	SELL	$13.02 - $21.3 $5,793 - $9,478	-445 Reduced 3.1%	13,911 $211,000
Q4 2023 Feb 14, 2024	BUY	$6.68 - $18.81 $1,075 - $3,028	161 Added 1.13%	14,356 $246,000
Q3 2023 Nov 13, 2023	BUY	$8.36 - $26.5 $15,549 - $49,290	1,860 Added 15.08%	14,195 $118,000
Q2 2023 Aug 14, 2023	SELL	$15.48 - $35.0 $76,486 - $172,935	-4,941 Reduced 28.6%	12,335 $306,000
Q1 2023 May 12, 2023	SELL	$10.23 - $19.34 $5,626 - $10,637	-550 Reduced 3.09%	17,276 $260,000
Q4 2022 Feb 14, 2023	BUY	$5.01 - $11.83 $3,116 - $7,358	622 Added 3.62%	17,826 $210,000
Q3 2022 Nov 14, 2022	BUY	$4.57 - $8.4 $9,990 - $18,362	2,186 Added 14.56%	17,204 $102,000
Q1 2022 May 13, 2022	SELL	$7.81 - $20.45 $343 - $899	-44 Reduced 0.29%	15,018 $143,000
Q4 2021 Feb 10, 2022	SELL	$15.2 - $35.51 $1,717 - $4,012	-113 Reduced 0.74%	15,062 $286,000
Q3 2021 Nov 12, 2021	BUY	$21.78 - $40.45 $3,179 - $5,905	146 Added 0.97%	15,175 $505,000
Q2 2021 Aug 09, 2021	BUY	$32.5 - $48.96 $1,462 - $2,203	45 Added 0.3%	15,029 $583,000
Q1 2021 May 17, 2021	SELL	$41.61 - $54.3 $110,016 - $143,569	-2,644 Reduced 15.0%	14,984 $722,000
Q2 2020 Aug 12, 2022	BUY	$8.9 - $21.84 $156,889 - $384,995	17,628 New	17,628 $75,000

Others Institutions Holding TGTX

# of Institutions

395

Shares Held

90.5M

Call Options Held

1.79M

Put Options Held

1.9M

View Full List

About TG THERAPEUTICS, INC.

Ticker TGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 145,274,000
Market Cap $4.5B
Description
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...

More about TGTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Clark Financial Services Group Inc , based on Form 13F filings with the SEC.

News

Stay updated on Clark Financial Services Group Inc with notifications on news.

Account

Clark Financial Services Group Inc Tg Therapeutics, Inc. Transaction History